Hoa T Tran1, In-Ah Lee, Daren Low, Alan Kamba, Atsushi Mizoguchi, Hai N Shi, Chun G Lee, Jack A Elias, Emiko Mizoguchi. 1. *Gastrointestinal Unit and †Center for the Study of Inflammatory Bowel Disease, Department of Medicine, ‡Molecular Pathology Unit, Department of Pathology, and §Division of Mucosal Immunology, Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and ‖Section of Pulmonary and Critical Care Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
Abstract
BACKGROUND: Chitinase 3-like 1 (CHI3L1) is an inducible molecule on intestinal epithelial cells during the development of inflammatory bowel disease. METHODS: To investigate the role of CHI3L1 in bacterial infectious colitis, we orally inoculated pathogenic Salmonella typhimurium and potentially pathogenic adherent-invasive Escherichia coli (AIEC) LF82 virulent strain into C57Bl/6 wild-type mice or CHI3L1 knockout (KO) mice. RESULTS: Both S. typhimurium and AIEC LF82 were found to efficiently induce severe intestinal inflammation in wild-type mice but not in CHI3L1 KO mice. These bacteria-infected CHI3L1 KO mice exhibit decreased cellular infiltration, bacterial translocation, and production of interleukin (IL)-6 and IL-22, as compared with those of wild-type mice. More importantly, CHI3L1 KO mice displayed aberrant STAT3 activation after bacterial infections. Co-stimulation of CHI3L1 and IL-6, but not IL-22, synergistically activates STAT3 signaling pathway in intestinal epithelial cells in an NF-κB/MAPK-dependent manner. CONCLUSIONS: CHI3L1 promotes the onset of selected gram-negative bacterial infectious colitis through IL-6/STAT3 pathway.
BACKGROUND:Chitinase 3-like 1 (CHI3L1) is an inducible molecule on intestinal epithelial cells during the development of inflammatory bowel disease. METHODS: To investigate the role of CHI3L1 in bacterial infectious colitis, we orally inoculated pathogenic Salmonella typhimurium and potentially pathogenic adherent-invasive Escherichia coli (AIEC) LF82 virulent strain into C57Bl/6 wild-type mice or CHI3L1 knockout (KO) mice. RESULTS: Both S. typhimurium and AIECLF82 were found to efficiently induce severe intestinal inflammation in wild-type mice but not in CHI3L1 KO mice. These bacteria-infected CHI3L1 KO mice exhibit decreased cellular infiltration, bacterial translocation, and production of interleukin (IL)-6 and IL-22, as compared with those of wild-type mice. More importantly, CHI3L1 KO mice displayed aberrant STAT3 activation after bacterial infections. Co-stimulation of CHI3L1 and IL-6, but not IL-22, synergistically activates STAT3 signaling pathway in intestinal epithelial cells in an NF-κB/MAPK-dependent manner. CONCLUSIONS:CHI3L1 promotes the onset of selected gram-negative bacterial infectious colitis through IL-6/STAT3 pathway.
Authors: Emiko Mizoguchi; Atsushi Mizoguchi; Hidetoshi Takedatsu; Elke Cario; Ype P de Jong; Choon Jin Ooi; Ramnik J Xavier; Cox Terhorst; Daniel K Podolsky; Atul K Bhan Journal: Gastroenterology Date: 2002-01 Impact factor: 22.682
Authors: Sandeep K Singh; Reetika Bhardwaj; Katarzyna M Wilczynska; Catherine I Dumur; Tomasz Kordula Journal: J Biol Chem Date: 2011-09-27 Impact factor: 5.157
Authors: Charles S Dela Cruz; Wei Liu; Chuan Hua He; Adam Jacoby; Alex Gornitzky; Bing Ma; Richard Flavell; Chun Geun Lee; Jack A Elias Journal: Cell Host Microbe Date: 2012-07-19 Impact factor: 21.023
Authors: Chun Geun Lee; Carla A Da Silva; Charles S Dela Cruz; Farida Ahangari; Bing Ma; Min-Jong Kang; Chuan-Hua He; Seyedtaghi Takyar; Jack A Elias Journal: Annu Rev Physiol Date: 2011 Impact factor: 19.318
Authors: M Kawada; H Seno; K Kanda; Y Nakanishi; R Akitake; H Komekado; K Kawada; Y Sakai; E Mizoguchi; T Chiba Journal: Oncogene Date: 2011-11-07 Impact factor: 9.867
Authors: Chun Geun Lee; Dominik Hartl; Gap Ryol Lee; Barbara Koller; Hiroshi Matsuura; Carla A Da Silva; Myung Hyun Sohn; Lauren Cohn; Robert J Homer; Alexander A Kozhich; Alison Humbles; Jennifer Kearley; Anthony Coyle; Geoffrey Chupp; Jennifer Reed; Richard A Flavell; Jack A Elias Journal: J Exp Med Date: 2009-05-04 Impact factor: 14.307
Authors: Shernan G Holtan; Ashraf Shabaneh; Brian C Betts; Armin Rashidi; Margaret L MacMillan; Celalletin Ustun; Khalid Amin; Byron P Vaughn; Justin Howard; Alexander Khoruts; Mukta Arora; Todd E DeFor; Darrell Johnson; Bruce R Blazar; Daniel J Weisdorf; Jinhua Wang Journal: JCI Insight Date: 2019-08-08
Authors: Kevin Connolly; Mikael Lehoux; Ryan O'Rourke; Benedetta Assetta; Guzide Ayse Erdemir; Jack A Elias; Chun Geun Lee; Yu-Wen Alvin Huang Journal: Alzheimers Dement Date: 2022-03-02 Impact factor: 16.655
Authors: Ji Yeon Choi; In Jun Yeo; Ki Cheon Kim; Won Rack Choi; Jae-Kyung Jung; Sang-Bae Han; Jin Tae Hong Journal: J Neuroinflammation Date: 2018-08-11 Impact factor: 8.322